Reference no: EM132498474
Question A. Using the acquisition method and assuming that Petwoud dissolves Supagud, Inc. so it is no longer in business, prepare Petwoud Company's journal entry to record the acquisition of Supagud, Inc. at 1/1/20x1.
For B. and C. below, assume Supagud remains in business as a separate operating company and that, for internal accounting purposes, Petwoud accounts for their investment in Supagud, Inc. using the equity method:
Question B. Prepare Petwoud Company's journal entry to record the acquisition of Supagud, Inc. at 1/1/20x1.
Question C. Prepare Petwoud Company's worksheet consolidation journal entries for:
i. December 31, 20x1 and
ii. December 31, 20x2.
On 1/1/20x1, Petwoud Company acquired 100% of the $1 par value outstanding voting common stock of Sjipagud, Inc. for a cash payment of $600,000. At the acquisition date, the fair value of Petwoud Company's common stock was $20 per share. Below is the summary balance sheet information of Supagud, Inc. at acquisition (1/1/20x1):
|
Debit
|
Credit
|
Accounts payable
|
|
60,000
|
Accounts receivable
|
50,000
|
|
Additional paid-in capital
|
|
60,000
|
Buildings (net) (20-year life)
|
140,000
|
|
Cash and short-term investments
|
70,000
|
|
Common stock
|
|
300,000
|
Equipment (net) (8-year life)
|
240,000
|
|
Intangible assets (indefinite life)
|
110,000
|
|
Land
|
90,000
|
|
Long-term liabilities (mature 12/31/x3)
|
|
180,000
|
Retained earnings, 1/1/x1
|
|
120,000
|
Supplies
|
20.000
|
|
Totals
|
770.000
|
720.000
|
Book value of net equity
|
4R0 000
|
|
During fiscal year-ending 12/31/20x1 and 12/31/20x2, Supagud, Inc. generated net income and paid dividends as follows:
|
Net income
|
Dividends
|
20x1
|
$104,000
|
$13,000
|
20x2
|
$142,000
|
$30,000
|
As of 1/1/20x1, 53joucts, land had a fair value of $102,000, its buildings were valued at $188,000, and its equipment was appraised at $216,000. According to Petwoud Company's analysis, they will record any excess of consideration paid over fair value of assets and liabilities acquired as a Patent asset to be amortized over 6 years.